– Deven McGraw to
serve a 3-year term beginning in 2023 –
SAN
FRANCISCO, Dec. 19, 2022 /PRNewswire/ -- Invitae
(NYSE: NVTA), a leading medical genetics company, announced the
appointment by the U.S. Government Accountability Office (GAO) of
Deven McGraw, lead of data
stewardship and data sharing at Invitae, to the National Health
Information Technology Advisory Committee (HITAC).
Established as part of the 21st Century Cures Act in 2016, HITAC
provides recommendations to the National Coordinator for Health
Information Technology on policies, standards, implementation
specifications, and certification criteria relating to the
implementation of a health information technology infrastructure
that advances the electronic access, exchange, and use of health
information.
"I am honored to be appointed to HITAC to help shape the
nation's health information policy, particularly as it relates to
increasing access to important patient health data in a way that is
ethical and transparent," said McGraw. "Through my participation on
HITAC's 2022 Adopted Standards Task Force subcommittee, I've
already had the opportunity to advise on the existing set of ONC
adopted standards and am looking forward to continuing my work with
this impressive group on the full committee. Invitae's mission to
increase access to and interoperability of consented patient health
information will provide a valuable perspective as we work towards
the mission of improving healthcare IT."
McGraw's term will begin on January 1,
2023. McGraw also serves on a subcommittee advising the
State of California on its data
sharing framework policies and procedures. In her role at Invitae,
McGraw is lead for data stewardship and data sharing. She
co-founded and was the Chief Regulatory Officer of Ciitizen, a
health technology company acquired by Invitae that works to enable
patients to collect, manage, and share their medical information.
Her previous experience includes serving as the Deputy Director of
Health Information Privacy within the U.S. Department of Health and
Human Services Office of Civil Rights, as the Acting Chief Privacy
Officer for the Office of the National Coordinator for Health IT,
and as a partner with Manatt, Phelps & Phillips, LLP. McGraw
received her Juris Doctor from Georgetown
University Law Center and her Master of Public Health from
Johns Hopkins Bloomberg School of Public Health.
For more information on the committee, visit the HITAC
website.
About Invitae
Invitae is a leading medical genetics
company trusted by millions of patients and their providers to
deliver timely genetic information simplified by digital
technology. With accurate and actionable answers to strengthen
medical decision-making, Invitae gives individuals and their
families powerful, personalized insights that could improve and
extend their lives. Invitae's genetics experts apply a rigorous
approach to data and research, serving as the foundation of their
mission: to bring comprehensive genetic information into mainstream
medicine to improve healthcare for billions of people.
To learn more, visit invitae.com and follow for updates
on Twitter, Instagram, Facebook and LinkedIn
@Invitae.
Safe Harbor Statement
This press release
contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, including
statements relating to the company's mission to increase access to
and interoperability of consented patient health information.
Forward-looking statements are subject to risks and uncertainties
that could cause actual results to differ materially, and reported
results should not be considered as an indication of future
performance. These risks and uncertainties include, but are not
limited to: the company's history of losses; the company's ability
to compete; the company's failure to manage growth effectively; the
company's need to scale its infrastructure in advance of demand for
its tests and to increase demand for its tests; the company's
ability to use rapidly changing genetic data to interpret test
results accurately and consistently; security breaches, loss of
data and other disruptions; laws and regulations applicable to the
company's business; and the other risks set forth in the company's
filings with the Securities and Exchange Commission, including the
risks set forth in the company's Quarterly Report on Form 10-Q for
the quarter ended September 30, 2022.
These forward-looking statements speak only as of the date hereof,
and Invitae Corporation disclaims any obligation to
update these forward-looking statements.
Contact:
Renee
Kelley
pr@invitae.com
(628)
213-3283
View original content to download
multimedia:https://www.prnewswire.com/news-releases/invitae-executive-appointed-to-national-health-information-technology-advisory-committee-301706433.html
SOURCE Invitae Corporation